Authors:
Mantz, CA
Vokes, EE
Stenson, K
Kies, MS
Mittal, B
Witt, ME
List, MA
Weichselbaum, RR
Haraf, DJ
Citation: Ca. Mantz et al., Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer, CANCER J, 7(2), 2001, pp. 140-148
Authors:
Mantz, CA
Vokes, EE
Kies, MS
Mittal, B
Witt, ME
List, MA
Weichselbaum, RR
Haraf, DJ
Citation: Ca. Mantz et al., Sequential induction chemotherapy and concomitant chemoradiotherapy in themanagement of locoregionally advanced laryngeal cancer, ANN ONCOL, 12(3), 2001, pp. 343-347
Citation: N. Mehta et al., Surgical approach to organ preservation in the treatment of cancer of the larynx - The Weinstein article reviewed, ONCOLOGY-NY, 15(6), 2001, pp. 799-801
Authors:
George, CM
Haraf, DJ
Mauer, AM
Krauss, SA
Hoffman, PC
Rudin, CM
Szeto, L
Vokes, EE
Citation: Cm. George et al., A phase I trial of the oral platinum analogue JM216 with concomitant radiotherapy in advanced malignancies of the chest, INV NEW DR, 19(4), 2001, pp. 303-310
Authors:
Brockstein, B
Haraf, DJ
Stenson, K
Sulzen, L
Witt, ME
Weichselbaum, RW
Vokes, EE
Citation: B. Brockstein et al., A phase I-II study of concomitant chemoradiotherapy with paclitaxel (one-hour infusion), 5-fluorouracil and hydroxyurea with granulocyte colony stimulating factor support for patients with poor prognosis head and neck cancer, ANN ONCOL, 11(6), 2000, pp. 721-728
Authors:
Stenson, KM
Haraf, DJ
Pelzer, H
Recant, W
Kies, MS
Weichselbaum, RR
Vokes, EE
Citation: Km. Stenson et al., The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy - The feasibility of selective neck dissection, ARCH OTOLAR, 126(8), 2000, pp. 950-956
Authors:
Kies, MS
Haraf, DJ
Rosen, F
Stenson, K
List, M
Brockstein, B
Chung, T
Mittal, BB
Pelzer, H
Portugal, L
Rademaker, A
Weichselbaum, R
Vokes, EE
Citation: Ms. Kies et al., Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer, J CL ONCOL, 19(7), 2000, pp. 1961-1969
Authors:
Vokes, EE
Kies, MS
Haraf, DJ
Stenson, K
List, M
Humerickhouse, R
Dolan, ME
Pelzer, H
Sulzen, L
Witt, ME
Hsieh, YC
Mittal, BB
Weichselbaum, RR
Citation: Ee. Vokes et al., Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer, J CL ONCOL, 18(8), 2000, pp. 1652-1661
Citation: Ee. Vokes et al., The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer, SEMIN ONCOL, 27(4), 2000, pp. 34-38
Authors:
Ferguson, MK
Wang, J
Hoffman, PC
Haraf, DJ
Olak, J
Masters, GA
Vokes, EE
Citation: Mk. Ferguson et al., Sex-associated differences in survival of patients undergoing resection for lung cancer, ANN THORAC, 69(1), 2000, pp. 245-249
Authors:
Lee, MH
Vokes, EE
Rosen, A
Witt, ME
Weichselbaum, RR
Haraf, DJ
Citation: Mh. Lee et al., Multimodality therapy in advanced paranasal sinus carcinoma: Superior long-term results, CA J SCI AM, 5(4), 1999, pp. 219-223
Authors:
Humerickhouse, RA
Dolan, ME
Haraf, DJ
Brockstein, B
Stenson, K
Kies, M
Sulzen, L
Ratain, MJ
Vokes, EE
Citation: Ra. Humerickhouse et al., Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrentor advanced head and neck cancer, CLIN CANC R, 5(2), 1999, pp. 291-298
Authors:
Vokes, EE
Haraf, DJ
Brockstein, BE
Weichselbaum, RR
Citation: Ee. Vokes et al., Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapyfor poor-prognosis head and neck cancer, SEM RAD ONC, 9(2), 1999, pp. 70-76
Authors:
Haraf, DJ
Kies, M
Rademaker, AW
Stenson, K
Mittal, B
Pelzer, H
Wenig, B
Witt, ME
Sulzen, L
Weichselbaum, RR
Vokes, EE
Citation: Dj. Haraf et al., Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer, J CL ONCOL, 17(2), 1999, pp. 638-644